|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Oyster Point Pharma, Inc. (OYST) |
|
|
$11.17 0.00 (0.00%) as of 4:30 Fri 12/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
21,360,000 |
Market
Cap: |
238.59(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.17 - $11.17 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Oyster Point Pharma is a biopharmaceutical company focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. Co.'s development pipeline includes: Small Molecule Programs, which consist of Tyrvaya (varenicline solution) Nasal Spray for the indication of dry eye disease, and OC-01 (varenicline solution) nasal spray for the indication of Neurotrophic Keratopathy Stage 1; and ETF Gene Therapy Approach, which consists of OC-101 adeno-associated virus (AAV)-Nerve Growth Factor for the indication of Neurotrophic Keratopathy Stage 2 and 3, and OC-103 AAV for the indication of Vernal Keratoconjunctivitis/Severe Allergic Conjunctivitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Murray Mark Anthony |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
122,086 |
|
- |
|
Weisner Aimee S |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
36,764 |
|
- |
|
Atieh Michael G |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
26,734 |
|
- |
|
Eliades George Christopher |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
28,624 |
|
- |
|
Behbahani Ali |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
13,639 |
|
- |
|
Santel Donald J |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
13,687 |
|
- |
|
Tsai Benjamin |
Director |
|
2022-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,573 |
13,639 |
|
- |
|
Lochner Daniel |
Chief Financial Officer |
|
2022-01-29 |
4 |
D |
$11.70 |
$10,975 |
D/D |
(938) |
76,525 |
|
- |
|
Nau Jeffrey |
President and CEO |
|
2022-01-29 |
4 |
D |
$11.70 |
$30,502 |
D/D |
(2,607) |
148,713 |
|
- |
|
Snisarenko John |
Chief Commercial Officer |
|
2022-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,100 |
30,322 |
|
- |
|
Lochner Daniel |
Chief Financial Officer |
|
2022-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
77,721 |
|
- |
|
Nau Jeffrey |
President and CEO |
|
2022-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
46,700 |
157,598 |
|
- |
|
Link William J Phd |
Director |
|
2022-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
6,839 |
2,074 |
|
- |
|
Versant Side Fund Iv, L.p. |
10% Owner |
|
2022-01-05 |
4 |
AS |
$0.00 |
$0 |
I/I |
(253,030) |
2,465 |
|
-70% |
|
Versant Side Fund Iv, L.p. |
10% Owner |
|
2022-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
51,556 |
51,556 |
|
- |
|
Clare Ozawa |
Director |
|
2022-01-05 |
4 |
AS |
$0.00 |
$0 |
I/I |
(253,030) |
2,465 |
|
-70% |
|
Clare Ozawa |
Director |
|
2022-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
120 |
11,064 |
|
- |
|
Clare Ozawa |
Director |
|
2022-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
51,556 |
51,556 |
|
- |
|
Clare Ozawa |
Director |
|
2021-12-21 |
4 |
AS |
$0.00 |
$0 |
I/I |
(253,030) |
3,726 |
|
-60% |
|
Clare Ozawa |
Director |
|
2021-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
120 |
10,944 |
|
- |
|
Clare Ozawa |
Director |
|
2021-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
51,556 |
51,556 |
|
- |
|
Link William J Phd |
Director |
|
2021-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
6,838 |
1,673 |
|
- |
|
Versant Side Fund Iv, L.p. |
10% Owner |
|
2021-12-21 |
4 |
AS |
$0.00 |
$0 |
I/I |
(253,030) |
3,726 |
|
-60% |
|
Versant Side Fund Iv, L.p. |
10% Owner |
|
2021-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
51,556 |
51,556 |
|
- |
|
Lochner Daniel |
Chief Financial Officer |
|
2021-11-01 |
4 |
OE |
$11.51 |
$98,871 |
D/D |
8,590 |
58,221 |
|
- |
|
140 Records found
|
|
Page 2 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|